Cargando…

Novel Strategies for Treating Castration-Resistant Prostate Cancer

The development of castration resistance is an inevitable pathway for the vast majority of patients with advanced prostate cancer. Recently, there have been significant breakthroughs in the understanding and management options of castration-resistant prostate cancer. Three novel hormonal agents show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, David Ka-Wai, Chiu, Peter Ka-Fung, Ng, Chi-Fai, Teoh, Jeremy Yuen-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066514/ https://www.ncbi.nlm.nih.gov/pubmed/33801751 http://dx.doi.org/10.3390/biomedicines9040339

Ejemplares similares

The Emerging Clinical Role of Spermine in Prostate Cancer
por: Peng, Qiang, et al.
Publicado: (2021)

Identification of piRNA Targets in Urinary Extracellular Vesicles for the Diagnosis of Prostate Cancer
por: Peng, Qiang, et al.
Publicado: (2021)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
por: Chiu, Peter Ka-Fung, et al.
Publicado: (2016)

High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform
por: Yee, Chi-Hang, et al.
Publicado: (2021)

A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions
por: Chan, Vinson Wai-Shun, et al.
Publicado: (2020)

Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers
por: Tsoi, Tik-Hung, et al.
Publicado: (2016)

A Comprehensive Community-Based Prevalence Study on Nocturia in Hong Kong Male Adults
por: Yuen, John Wai-Man, et al.
Publicado: (2021)

Predictive Values of Nocturia and Its Voiding Frequency on the Aging Males’ Symptoms
por: Yuen, John Wai-Man, et al.
Publicado: (2022)

Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate
por: Yee, Chi-Hang, et al.
Publicado: (2016)

Risk of cardiovascular thrombotic events after surgical castration versus gonadotropin-releasing hormone agonists in Chinese men with prostate cancer
por: Teoh, Jeremy YC, et al.
Publicado: (2015)

Transurethral resection of prostate for acute urinary retention is linked to shorter survival in younger men
por: Teoh, Jeremy Yuen-Chun, et al.
Publicado: (2019)

Oral antibiotics perturbation on gut microbiota after prostate biopsy
por: Li, Joseph Kai Man, et al.
Publicado: (2022)

Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients
por: Liang, Yonghao, et al.
Publicado: (2022)

Versatility of Retzius-Sparing Prostatectomy: Its Application in Renal Transplant Patient and En-bloc Abdominal-Perineal Resection
por: Yee, Chi Hang, et al.
Publicado: (2021)

Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
por: Jia, Lin, et al.
Publicado: (2018)

Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy
por: Yu, Simon Chun Ho, et al.
Publicado: (2016)

Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Urinary Cell-Free DNA in Bladder Cancer Detection
por: Tse, Ryan Tsz-Hei, et al.
Publicado: (2021)

The effect of renal cortical thickness on the treatment outcomes of kidney stones treated with shockwave lithotripsy
por: Ng, Chi-Fai, et al.
Publicado: (2015)

In vitro cytotoxicity of human urine and its potential toxic parameters towards bladder cancer cells
por: Zhao, Hongda, et al.
Publicado: (2022)

Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer
por: Zobniw, Chrystia M, et al.
Publicado: (2014)

Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men
por: Isotani, Shuji, et al.
Publicado: (2023)

Time trend and characteristics of prostate cancer diagnosed in Hong Kong (China) in the past two decades
por: Wong, Ho-Fai, et al.
Publicado: (2019)

Hemopatch to Prevent Lymphatic Leak after Robotic Prostatectomy and Pelvic Lymph Node Dissection: A Randomized Controlled Trial
por: Teoh, Jeremy Yuen-Chun, et al.
Publicado: (2022)

Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation
por: Yee, Chi-Hang, et al.
Publicado: (2022)

New Therapeutics to Treat Castrate-Resistant Prostate Cancer
por: Acar, Ömer, et al.
Publicado: (2013)

Current Treatment Strategies for Castration-Resistant Prostate Cancer
por: Kim, Se Joong, et al.
Publicado: (2011)

Effect of androgen deprivation therapy on cardiovascular function in Chinese patients with advanced prostate cancer: a prospective cohort study
por: Ng, Chi-fai, et al.
Publicado: (2020)

Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells
por: Gao, Weijie, et al.
Publicado: (2022)

Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong Kong
por: Bouttell, Janet, et al.
Publicado: (2019)

How to manage patients with suspected upper tract urothelial carcinoma in the pandemic of COVID-19?
por: Lee, Hsiang-Ying, et al.
Publicado: (2021)

Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease
por: Henriquez, Ivan, et al.
Publicado: (2021)

Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
por: Bumbaca, Brandon, et al.
Publicado: (2018)

The Risk of Upper Urinary Tract Involvement in Patients With Ketamine-Associated Uropathy
por: Yee, Chi-Hang, et al.
Publicado: (2017)

Novel agents in the management of castration resistant prostate cancer
por: Chaturvedi, Shruti, et al.
Publicado: (2014)

Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer
por: Leung, Yuet-Kin, et al.
Publicado: (2014)

Prescription of Chinese Herbal Medicine in Pattern-Based Traditional Chinese Medicine Treatment for Depression: A Systematic Review
por: Yeung, Wing-Fai, et al.
Publicado: (2015)

Impact of endoscopic ultrasound-guided gallbladder drainage on reducing costs of reintervention and unplanned readmission: a budget impact analysis
por: Chan, Shannon Melissa, et al.
Publicado: (2022)

Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant Prostate Cancer
por: Kase, Adam M, et al.
Publicado: (2020)

Importance of cycles of chemotherapy and postdocetaxel novel therapies in metastatic castration-resistant prostate cancer
por: Poon, Darren M.C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hv2mv4hh172bdvgths9biti1ut